<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343432</url>
  </required_header>
  <id_info>
    <org_study_id>03-2008/23</org_study_id>
    <nct_id>NCT02343432</nct_id>
  </id_info>
  <brief_title>Is the Efficacy of Epidural Steroid Injections Related to the Different Volume Injections?</brief_title>
  <official_title>Is the Efficacy of Epidural Steroid Injections Related to the Different Volume Injections? :A Randomised, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neslihan Uztüre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Gaziantep</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yeditepe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was aimed to investigate the impact of using different epidural volumes.

      Patients with acute discogenic pain were included in the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: This study was aimed to investigate the impact of using different epidural
      volumes.

      Methods: Seventy five patients with acute discogenic pain were included in the study.The
      patients were randomly assigned to three groups. All patients received a single epidural dose
      of triamcinolone [80 mg] and 12.5 mg bupivacaine combination. The patients in Group 1, Group
      2 and Group 3 received a volume of 10 mL, 15 mL, and 20 mL by epidural injections,
      respectively. The efficacy of treatment was assessed with VAS (visual analog scale) [O= no
      pain, 10 = unbearable pain], SLET(straight leg elevation test) [0° = worst, 85° = best], and
      Oswestry Disability Index; ODI [0% to 20%:minimal disability , 80% to 100%:bed bound
      patients] before and 2 weeks after the EPSI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS (visual analog scale) [O= no pain, 10 = unbearable pain]</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>SLET(straight leg elevation test) [0° = worst, 85° = best]</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index; ODI [0% to 20%:minimal disability , 80% to 100%:bed bound patients]</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Epidural Volume 10mL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural Volume 10mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 10mL Intervention: Drug: Bupivacaine 12.5mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Volume 15mL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural Volume 15mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 15 mL Intervention: Drug: Bupivacaine 12.5mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Volume 20mL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural Volume 20mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 20 mL Intervention: Drug: Bupivacaine 12.5mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>Triamcinolone</description>
    <arm_group_label>Epidural Volume 10mL</arm_group_label>
    <arm_group_label>Epidural Volume 15mL</arm_group_label>
    <arm_group_label>Epidural Volume 20mL</arm_group_label>
    <other_name>Kelanocort</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural Volume</intervention_name>
    <description>Epidural Volume</description>
    <arm_group_label>Epidural Volume 10mL</arm_group_label>
    <arm_group_label>Epidural Volume 15mL</arm_group_label>
    <arm_group_label>Epidural Volume 20mL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Bupivacaine</description>
    <arm_group_label>Epidural Volume 10mL</arm_group_label>
    <arm_group_label>Epidural Volume 15mL</arm_group_label>
    <arm_group_label>Epidural Volume 20mL</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute discogenic pain with less than three months duration not responding to other
             modalities of conservative management [NSAIDs, physiotherapy, bracing, etc.],

          -  radiological disc bulging accompanying unilateral root impingement symptoms,

          -  an Oswestry daily activity score more than 20 percent, and

          -  resistance to treatment.

        Exclusion Criteria:

          -  Patients with bilateral root impingement symptoms, neurological deficits, and/or
             history of previous lumbar disc surgery, severe cardiac, pulmonary, gastrointestinal,
             renal diseases, glaucoma, urinary retention, and/or known allergy to the drugs used in
             the study were excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lütfiye Budak</last_name>
    <role>Study Director</role>
    <affiliation>University of Gaziantep</affiliation>
  </overall_official>
  <reference>
    <citation>Runu R, Sinha NK, Pai R, Shankar PR, Vijayabhaskar P. Our experience with epidural steroid injections in management of low backpain and sciatica. Kathmandu Univ Med J (KUMJ). 2005 Oct-Dec;3(4):349-54.</citation>
    <PMID>16449834</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2014</study_first_submitted>
  <study_first_submitted_qc>January 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>January 15, 2015</last_update_submitted>
  <last_update_submitted_qc>January 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Yeditepe University Hospital</investigator_affiliation>
    <investigator_full_name>Neslihan Uztüre</investigator_full_name>
    <investigator_title>assistant proffessor</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Adverse Effect</keyword>
  <keyword>Spinal</keyword>
  <keyword>Epidural</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>December 28, 2015</submitted>
    <returned>February 1, 2016</returned>
    <submitted>March 21, 2018</submitted>
    <returned>April 17, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

